Zhejiang Apeloa Jiayuan Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding US DMF Number 38624.
Remarkably, this DMF maintains an Active status since its submission on August 01, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 26, 2023, and payment made on August 17, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II